Hence, the incorporation of nanomaterials such as nanoparticles and aptamers into technologies designed for the detection of prostate-specific antigen could be a great fit for clinical electrochemical assays for the diagnosis of prostate cancer. The gene discussed is KLK3; the disease is prostate carcinoma.